Skip to main content
. 2015 Jul-Sep;13(3):357–363. doi: 10.1590/S1679-45082015AO3313

Table 1. Baseline characteristics of study participants.

Characteristic <65 years 317 (37.4%) n (%) ≥65 years 531 (62.6%) n (%) p value
Male sex 178 (56.2) 310 (58.4) 0.566
Underlying disease      
Systemic hypertension 89 (28.1) 280 (52.9) <0.001
Diabetes mellitus 69 (21.8) 173 (32.7) 0.001
Neoplasms 73 (23.0) 146 (27.6) 0.142
Congestive heart failure 12 (3.8) 73 (13.8) <0.001
Coronary insufficiency 18 (5.7) 72 (13.6) <0.001
COPD 7 (2.2) 67 (12.7) <0.001
Chronic renal failure 10 (3.2) 44 (8.3) 0.003
Chronic renal failure RRT 12 (3.8) 30 (5.7) 0.255
Liver cirrhosis 60 (18.9) 20 (3.8) <0.001
Solid organ transplantation 66 (20.8) 14 (2.6) <0.001
HIV 3 (0.9) 1 (0.2) 0.151
Number of comorbid conditions     <0.001
0 85 (26.8) 75 (14.1)  
1 109 (34.4) 161 (30.3)  
2 80 (25.2) 168 (31.7)  
≥3 43 (13.6) 127 (23.9)  
Source of infection      
Respiratory tract 144 (45.4) 307 (57.8) <0.001
Urinary tract 51 (16.1) 85 (16.0) 1.000
Abdominal 84 (26.5) 77 (14.5) <0.001
Skin and soft tissue 9 (2.8) 25 (4.7) 0.208
Others 12 (3.8) 20 (3.8) 1.000
Bloodstream 13 (4.1) 10 (1.9) 0.078
Unknown 4 (1.3) 7 (1.3) 1.000
Site of diagnosis, n (%)      
Emergency department 155 (48.9) 270 (50.8) 0.619
Hospital floor 107 (33.8) 104 (19.6) <0.001
Intermediary care 18 (5.7) 93 (17.5) <0.001
Intensive care unit 33 (10.4) 61 (11.5) 0.653
Other 4 (1.3) 3 (0.6) 0.434

p values are given by χ2 test or Fisher’s exact test for binary variables and Unpaired test for continuous variables. COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; RRT: renal replacement therapy.